VEGF, as well as other immunosuppressive factors, can attenuate the expression of adhesion molecules (e.g., intracellular adhesion molecule 1, vascular adhesion molecule 1, CD34) on the vascular endothelium of the tumor. Here, VEGFA is linked to neoplasm.